Magnesium is required as a cofactor in more than 300 enzymatic reactions in the human body — involved in ATP synthesis, DNA repair, nerve signal transmission, muscle contraction and relaxation, and the activation of vitamin D. Given this central role, what strikes me about the epidemiological data is how common inadequate magnesium intake has become in industrialized populations, and how underappreciated this deficiency remains in routine clinical practice.
The Deficiency Data
Rosanoff et al. published a comprehensive analysis in Nutrition Reviews in 2012 drawing on NHANES (National Health and Nutrition Examination Survey) data across multiple collection cycles, estimating that approximately 48% of Americans consume less than the estimated average requirement (EAR) for magnesium. The EAR is set at 320 to 330 mg per day for adult women and 350 to 360 mg per day for adult men; the Recommended Dietary Allowance is set somewhat higher to cover 97 to 98 percent of the population. Processing strips magnesium substantially: refined white flour contains roughly 78% less magnesium than whole wheat flour. Most Americans eat very little whole grain food and consume a diet dominated by refined and processed products with low mineral density.
Groups with particularly elevated risk for magnesium deficiency include people with type 2 diabetes (higher urinary magnesium losses from glycosuria-driven diuresis), people with alcohol use disorder, older adults (both reduced dietary intake and reduced GI absorption efficiency with age), individuals using proton pump inhibitors long-term (PPIs impair intestinal magnesium absorption), and people with celiac disease or Crohn’s disease where small intestinal absorption is compromised.
Forms of Magnesium: What the Bioavailability Research Shows
Not all magnesium supplements are equivalent, and the form matters substantially for both bioavailability and gastrointestinal side effects. Magnesium glycinate — magnesium bound to glycine — is a chelated form with high bioavailability and minimal laxative effect. The glycine component has independent relaxation effects via glycine receptors in the central nervous system, which may contribute to the sleep benefits attributed to this form. This is generally the preferred form for supplementation aimed at sleep quality or anxiety support.
Magnesium citrate, bound to citric acid, has good bioavailability and mild osmotic laxative effect at higher doses, making it useful for individuals with constipation and less ideal for those who are not. Magnesium malate, bound to malic acid, has good bioavailability and is frequently used in protocols for muscle fatigue, given malic acid’s role in the citric acid cycle. Magnesium oxide is the form to avoid for supplementation purposes: bioavailability has been measured at approximately 4% in some studies, meaning the large majority passes through the gut without absorption. It functions primarily as an osmotic laxative. Despite being the cheapest form and the most commonly included in low-cost multivitamins, it is poorly suited for addressing magnesium deficiency.
Clinical Applications with Evidence
Sleep quality has received meaningful attention in magnesium research. Nielsen et al. published findings in Magnesium Research in 2010 examining older adults with magnesium deficiency and found that supplementation improved sleep efficiency, total sleep time, and early morning awakening, alongside reductions in inflammatory markers including IL-6 and CRP. The sample size was modest (n=100), which is a genuine limitation, but the mechanistic basis is credible: magnesium regulates GABA receptors — the primary inhibitory neurotransmitter system — and melatonin secretion, and deficiency has been associated with hyperactivation of the sympathetic nervous system and elevated cortisol.
The cardiovascular evidence is primarily epidemiological. Volpe (2013, Advances in Nutrition) reviewed the relationship between magnesium status and cardiovascular disease, finding consistent associations between higher magnesium intake and reduced risk of hypertension, coronary artery disease, and type 2 diabetes across multiple cohort studies. Magnesium regulates vascular smooth muscle tone and has calcium antagonist-like effects on arterial function. RCT evidence for blood pressure reduction with supplementation is positive but modest and most consistent in individuals with baseline deficiency.
Dosing: Elemental vs Salt Weight
A frequent source of confusion is the difference between elemental magnesium content and the weight of the magnesium salt listed on the label. Magnesium glycinate is approximately 14% elemental magnesium by weight, meaning a 400 mg capsule of magnesium glycinate delivers roughly 56 mg of elemental magnesium. Magnesium citrate is approximately 16% elemental magnesium. Clinical recommendations from the literature typically reference elemental magnesium doses in the range of 200 to 400 mg per day. When comparing products, always compare elemental magnesium, not salt weight. Quality supplement brands list both; cheaper products display only the salt weight on the front label.
Testing: Why Serum Levels Can Mislead
Standard serum magnesium tests are a poor proxy for magnesium status. Approximately 99% of the body’s magnesium is intracellular — located in bone, muscle, and soft tissue — with only about 1% in serum. The body tightly regulates serum magnesium through bone and muscle release, meaning serum levels remain in the reference range until tissue stores are substantially depleted. RBC magnesium, which measures magnesium within red blood cells, is a more accurate reflection of intracellular status and is ordered by some integrative physicians, though it is not routinely available in standard clinical panels. The practical implication: a normal serum magnesium result does not rule out deficiency.
Not medical advice. Content is informational only. Consult a qualified healthcare provider before making changes to your health regimen.
Leave a Reply